© PETER DEJONG, AP Magic mushrooms, such as these from the Netherlands, contain a hallucinogen call psilocybin. A synthetic form of the drug was used in two new studies. Psychedelic medicine, long taboo, is moving toward the mainstream: Two new studies show the hallucinogenic drug psilocybin might relieve anxiety and depression in cancer patients.
Dozens of distressed patients, treated under controlled conditions at two prestigious medical centers, saw spirit-lifting effects that lasted at least several weeks after taking the “magic mushroom” drug, according to results published Thursday in The Journal of Psychopharmacology.
See the article at.